Unilabs Drug Development Services changes brand to York Bioanalytical Solutions
In order to develop its position as a leading Independent Bioanalytical CRO in Europe, Unilabs Drug Development Services changes brand to York Bioanalytical Solutions, YBS, as of today.
Yvonne Lech, Managing Director of Unilabs Denmark stated: “Since becoming part of the Unilabs group in May 2008, YBS has integrated with Unilabs Copenhagen to share quality and regulatory competencies & scientists, as well as supplementing each other’s core competencies.
It is now time to introduce a common brand name for Unilabs activities within Drug Development Services.
The “new” Unilabs York Bioanalytical Solutions is a significant independent supplier of bioanalysis for both NCEs and NBEs as well as biomarkers in Europe. In addition we take the pain out of sample logistics.
The new brand is designed to acknowledge the qualities associated with YBS, the premier independent UK bioanalytical laboratory for drug development support.
As part of the Unilabs group, YBS in York has integrated with its sister site in Copenhagen and the integrated company can offer LC-MS/MS as well as additional high quality bioanalytical services, including traditional immunoassay using ELISA & RIA, biomarker analysis, cell based assays, GC-MS, ICP-MS and an unparalleled logistics service dedicated to bioanalysis.
YBS is dedicated to continuous renewal of its technical platforms and recent new innovations include; new immunoassay technology comprising the Gyrolab system for automating high throughput immunoassay methods and the Meso Scale Discovery (MSD) system for added sensitivity, selectivity and multiple biomarker analysis using electrochemiluminescence.
The “new” Unilabs York Bioanalytical Solutions will continue to offer the unsurpassed quality and scientific deliverance that has always been associated with the brand YBS.
For more information please visit www.yorkbio.com
OR please contact:
Yvonne Lech; Managing Director Unilabs a.s.
Telephone: +45 23 44 12 84;
email: yvonne.lech@unilabs.com
Unilabs – Answers to European Diagnostics Services
Unilabs is Europe’s leading diagnostic services company within laboratory and radiology services. We have 3,600 employees and operate more than 90 laboratories and 30 radiology units in Belgium, Denmark, Finland, France, Italy, Norway, Portugal, Russia, Spain, Sweden, Switzerland, and the United Kingdom. Our customers are both public and private healthcare units such as hospitals, outpatients clinics, GPs, occupational health units, insurance companies, drug development companies and CROs. We supply medical laboratory analyses and services within clinical biochemistry, clinical haematology, clinical microbiology, cellular pathology, transfusion medicine and clinical trials. Our radiology units supply services within conventional X-ray, mammography, MRI, CT, ultrasound, fluoroscopy, osteoporosis, nuclear medicine and teleradiology.